{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T03:49:32Z","timestamp":1788234572810,"version":"build-2803163510"},"reference-count":162,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,3,28]],"date-time":"2026-03-28T00:00:00Z","timestamp":1774656000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,5,7]],"date-time":"2026-05-07T00:00:00Z","timestamp":1778112000000},"content-version":"vor","delay-in-days":40,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Science and Technology Plan Joint Program of Liaoning Province","award":["2024-MSLH-560"],"award-info":[{"award-number":["2024-MSLH-560"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Biol Toxicol"],"DOI":"10.1007\/s10565-026-10184-1","type":"journal-article","created":{"date-parts":[[2026,3,28]],"date-time":"2026-03-28T20:43:34Z","timestamp":1774730614000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["The m6A-circRNA axis: a therapeutic prospect for gastric cancer"],"prefix":"10.1007","volume":"42","author":[{"given":"Zijia","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yiwei","family":"Gu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Gu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qing-Bai","family":"She","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuxin","family":"Tong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,3,28]]},"reference":[{"key":"10184_CR1","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1038\/s41575-022-00703-w","volume":"20","author":"M Alsina","year":"2023","unstructured":"Alsina M, Arrazubi V, Diez M, Tabernero J. Current developments in gastric cancer: from molecular profiling to treatment strategy. Nat Rev Gastroenterol Hepatol. 2023;20:155\u201370. https:\/\/doi.org\/10.1038\/s41575-022-00703-w.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10184_CR2","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1007\/s10142-020-00753-w","volume":"20","author":"K Balakrishnan","year":"2020","unstructured":"Balakrishnan K, Ganesan K. Occurrence of differing metabolic dysregulations, a glucose driven and another fatty acid centric in gastric cancer subtypes. Funct Integr Genomics. 2020;20:813\u201324. https:\/\/doi.org\/10.1007\/s10142-020-00753-w.","journal-title":"Funct Integr Genomics"},{"key":"10184_CR3","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1038\/s41568-020-0253-2","volume":"20","author":"I Barbieri","year":"2020","unstructured":"Barbieri I, Kouzarides T. Role of RNA modifications in cancer. Nat Rev Cancer. 2020;20:303\u201322. https:\/\/doi.org\/10.1038\/s41568-020-0253-2.","journal-title":"Nat Rev Cancer"},{"key":"10184_CR4","doi-asserted-by":"publisher","first-page":"941","DOI":"10.1038\/nbt.3330","volume":"33","author":"E Blanco","year":"2015","unstructured":"Blanco E, Shen H, Ferrari M. Principles of nanoparticle design for overcoming biological barriers to drug delivery. Nat Biotechnol. 2015;33:941\u201351. https:\/\/doi.org\/10.1038\/nbt.3330.","journal-title":"Nat Biotechnol"},{"key":"10184_CR5","doi-asserted-by":"publisher","first-page":"229","DOI":"10.3322\/caac.21834","volume":"74","author":"F Bray","year":"2024","unstructured":"Bray F, et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2024;74:229\u201363. https:\/\/doi.org\/10.3322\/caac.21834.","journal-title":"CA Cancer J Clin"},{"key":"10184_CR6","doi-asserted-by":"publisher","unstructured":"Cai A, Zhou X. Exosomal hsa_circ_0035277 enhances the malignancy of gastric cancer by interacting with the m6A reader ELAVL1. 2024. \nhttps:\/\/doi.org\/10.5114\/aoms\/178185.","DOI":"10.5114\/aoms\/178185"},{"key":"10184_CR7","doi-asserted-by":"publisher","DOI":"10.1016\/j.neo.2024.101049","volume":"57","author":"Z Cai","year":"2024","unstructured":"Cai Z, et al. ELAVL1 regulates PD-L1 mRNA stability to disrupt the infiltration of CD4-positive T cells in prostate cancer. Neoplasia. 2024;57:101049. https:\/\/doi.org\/10.1016\/j.neo.2024.101049.","journal-title":"Neoplasia"},{"key":"10184_CR8","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1080\/14737159.2025.2573461","volume":"25","author":"M Callegarin","year":"2025","unstructured":"Callegarin M, Angerilli V, Gasparello J, Fassan M. An evaluation of known predictive biomarkers for gastric cancer. Expert Rev Mol Diagn. 2025;25:753\u201373. https:\/\/doi.org\/10.1080\/14737159.2025.2573461.","journal-title":"Expert Rev Mol Diagn"},{"key":"10184_CR9","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-023-06241-w","volume":"14","author":"B Chen","year":"2023","unstructured":"Chen B, et al. m6A and m5C modification of GPX4 facilitates anticancer immunity via STING activation. Cell Death Dis. 2023;14:809. https:\/\/doi.org\/10.1038\/s41419-023-06241-w.","journal-title":"Cell Death Dis"},{"key":"10184_CR10","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-021-01475-8","volume":"20","author":"DL Chen","year":"2021","unstructured":"Chen DL, et al. The circular RNA circDLG1 promotes gastric cancer progression and anti-PD-1 resistance through the regulation of CXCL12 by sponging miR-141-3p. Mol Cancer. 2021;20:166. https:\/\/doi.org\/10.1186\/s12943-021-01475-8.","journal-title":"Mol Cancer"},{"key":"10184_CR11","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1016\/j.canlet.2016.12.006","volume":"388","author":"J Chen","year":"2017","unstructured":"Chen J, et al. Circular RNA profile identifies circPVT1 as a proliferative factor and prognostic marker in gastric cancer. Cancer Lett. 2017;388:208\u201319. https:\/\/doi.org\/10.1016\/j.canlet.2016.12.006.","journal-title":"Cancer Lett"},{"key":"10184_CR12","doi-asserted-by":"publisher","first-page":"4695","DOI":"10.1038\/s41467-019-12651-2","volume":"10","author":"RX Chen","year":"2019","unstructured":"Chen RX, et al. N(6)-methyladenosine modification of circNSUN2 facilitates cytoplasmic export and stabilizes HMGA2 to promote colorectal liver metastasis. Nat Commun. 2019;10:4695. https:\/\/doi.org\/10.1038\/s41467-019-12651-2.","journal-title":"Nat Commun"},{"key":"10184_CR13","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2024.107206","volume":"204","author":"XY Chen","year":"2024","unstructured":"Chen XY, et al. CircUGGT2 downregulation by METTL14-dependent m(6)A modification suppresses gastric cancer progression and cisplatin resistance through interaction with miR-186-3p\/MAP3K9 axis. Pharmacol Res. 2024;204:107206. https:\/\/doi.org\/10.1016\/j.phrs.2024.107206.","journal-title":"Pharmacol Res"},{"key":"10184_CR14","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2025.116375","volume":"44","author":"RX Chen","year":"2025","unstructured":"Chen RX, et al. m6A-mediated circG3BP1 translocation to stress granules promotes nucleation and senescence-linked chemoresistance. Cell Rep. 2025;44:116375. https:\/\/doi.org\/10.1016\/j.celrep.2025.116375.","journal-title":"Cell Rep"},{"key":"10184_CR15","doi-asserted-by":"publisher","DOI":"10.1186\/s12967-018-1582-8","volume":"16","author":"J Cheng","year":"2018","unstructured":"Cheng J, et al. Regulatory network of circRNA-miRNA-mRNA contributes to the histological classification and disease progression in gastric cancer. J Transl Med. 2018;16:216. https:\/\/doi.org\/10.1186\/s12967-018-1582-8.","journal-title":"J Transl Med"},{"key":"10184_CR16","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1056\/NEJMra1205406","volume":"368","author":"AM Choi","year":"2013","unstructured":"Choi AM, Ryter SW, Levine B. Autophagy in human health and disease. N Engl J Med. 2013;368:651\u201362. https:\/\/doi.org\/10.1056\/NEJMra1205406.","journal-title":"N Engl J Med"},{"key":"10184_CR17","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1038\/nature13480","volume":"513","author":"Comprehensive molecular characterization of gastric adenocarcinoma","year":"2014","unstructured":"Comprehensive molecular characterization of gastric adenocarcinoma. Nature. 2014;513:202\u20139. https:\/\/doi.org\/10.1038\/nature13480.","journal-title":"Nature"},{"key":"10184_CR18","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2025.1723383","volume":"16","author":"Q Dai","year":"2025","unstructured":"Dai Q, Yuan X, Dong H, Xue H. From immune suppression to immunotherapy sensitization: the dual roles of circRNAs in cancer progression. Front Immunol. 2025;16:1723383. https:\/\/doi.org\/10.3389\/fimmu.2025.1723383.","journal-title":"Front Immunol"},{"key":"10184_CR19","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1016\/j.jconrel.2016.11.015","volume":"244","author":"F Danhier","year":"2016","unstructured":"Danhier F. To exploit the tumor microenvironment: since the EPR effect fails in the clinic, what is the future of nanomedicine? J Control Release. 2016;244:108\u201321. https:\/\/doi.org\/10.1016\/j.jconrel.2016.11.015.","journal-title":"J Control Release"},{"key":"10184_CR20","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1016\/j.semcancer.2019.12.007","volume":"65","author":"SK Daniel","year":"2020","unstructured":"Daniel SK, Seo YD, Pillarisetty VG. The CXCL12-CXCR4\/CXCR7 axis as a mechanism of immune resistance in gastrointestinal malignancies. Semin Cancer Biol. 2020;65:176\u201388. https:\/\/doi.org\/10.1016\/j.semcancer.2019.12.007.","journal-title":"Semin Cancer Biol"},{"key":"10184_CR21","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-025-02478-5","volume":"24","author":"ZJ Deng","year":"2025","unstructured":"Deng ZJ. CircZFAND6 suppresses gastric cancer metastasis and reduces resistance to TKI therapy. Mol Cancer. 2025;24:305. https:\/\/doi.org\/10.1186\/s12943-025-02478-5.","journal-title":"Mol Cancer"},{"key":"10184_CR22","doi-asserted-by":"publisher","first-page":"2548","DOI":"10.1038\/s41388-024-03099-w","volume":"43","author":"P Ding","year":"2024","unstructured":"Ding P. N6-methyladenosine modified circPAK2 promotes lymph node metastasis via targeting IGF2BPs\/VEGFA signaling in gastric cancer. Oncogene. 2024;43:2548\u201363. https:\/\/doi.org\/10.1038\/s41388-024-03099-w.","journal-title":"Oncogene"},{"key":"10184_CR23","doi-asserted-by":"publisher","DOI":"10.1038\/s41420-023-01485-z","volume":"9","author":"SQ Ding","year":"2023","unstructured":"Ding SQ, et al. Role of N6-methyladenosine RNA modification in gastric cancer. Cell Death Discovery. 2023;9:241. https:\/\/doi.org\/10.1038\/s41420-023-01485-z.","journal-title":"Cell Death Discovery"},{"key":"10184_CR24","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1038\/nbt.3802","volume":"35","author":"SF Dowdy","year":"2017","unstructured":"Dowdy SF. Overcoming cellular barriers for RNA therapeutics. Nat Biotechnol. 2017;35:222\u20139. https:\/\/doi.org\/10.1038\/nbt.3802.","journal-title":"Nat Biotechnol"},{"key":"10184_CR25","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1016\/j.canlet.2021.11.031","volume":"526","author":"Y Du","year":"2022","unstructured":"Du Y, et al. Hypoxia-induced ebv-circLMP2A promotes angiogenesis in EBV-associated gastric carcinoma through the KHSRP\/VHL\/HIF1\u03b1\/VEGFA pathway. Cancer Lett. 2022;526:259\u201372. https:\/\/doi.org\/10.1016\/j.canlet.2021.11.031.","journal-title":"Cancer Lett"},{"key":"10184_CR26","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-022-01521-z","volume":"21","author":"HN Fan","year":"2022","unstructured":"Fan HN, et al. METTL14-mediated m(6)A modification of circORC5 suppresses gastric cancer progression by regulating miR-30c-2-3p\/AKT1S1 axis. Mol Cancer. 2022;21:51. https:\/\/doi.org\/10.1186\/s12943-022-01521-z.","journal-title":"Mol Cancer"},{"key":"10184_CR27","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1186\/s12951-024-02760-6","volume":"22","author":"Y Fei","year":"2024","unstructured":"Fei Y, et al. Circ_0008315 promotes tumorigenesis and cisplatin resistance and acts as a nanotherapeutic target in gastric cancer. Journal of Nanobiotechnology. 2024;22:519. https:\/\/doi.org\/10.1186\/s12951-024-02760-6.","journal-title":"Journal of Nanobiotechnology"},{"key":"10184_CR28","doi-asserted-by":"publisher","DOI":"10.1016\/j.cellsig.2023.111002","volume":"114","author":"H Guo","year":"2024","unstructured":"Guo H, et al. M6A reader YTHDF1 promotes malignant progression of laryngeal squamous carcinoma through activating the EMT pathway by EIF4A3. Cell Signal. 2024;114:111002. https:\/\/doi.org\/10.1016\/j.cellsig.2023.111002.","journal-title":"Cell Signal"},{"key":"10184_CR29","doi-asserted-by":"publisher","first-page":"968","DOI":"10.1038\/s41388-024-03260-5","volume":"44","author":"X Han","year":"2025","unstructured":"Han X, Xia L, Wu Y, Chen X, Wu X. m6A-modified circSTX6 as a key regulator of cervical cancer malignancy via SPI1 and IL6\/JAK2\/STAT3 pathways. Oncogene. 2025;44:968\u201382. https:\/\/doi.org\/10.1038\/s41388-024-03260-5.","journal-title":"Oncogene"},{"key":"10184_CR30","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","volume":"144","author":"D Hanahan","year":"2011","unstructured":"Hanahan D, Weinberg RA. Hallmarks of cancer: the next generation. Cell. 2011;144:646\u201374. https:\/\/doi.org\/10.1016\/j.cell.2011.02.013.","journal-title":"Cell"},{"key":"10184_CR31","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-022-04677-0","volume":"13","author":"Z He","year":"2022","unstructured":"He Z, Cai K, Zeng Z, Lei S, Cao W, Li X. Autophagy-associated circRNA circATG7 facilitates autophagy and promotes pancreatic cancer progression. Cell Death Dis. 2022;13:233. https:\/\/doi.org\/10.1038\/s41419-022-04677-0.","journal-title":"Cell Death Dis"},{"key":"10184_CR32","doi-asserted-by":"publisher","first-page":"19895","DOI":"10.1002\/jcp.28588","volume":"234","author":"Y Hong","year":"2019","unstructured":"Hong Y, et al. FNDC3B circular RNA promotes the migration and invasion of gastric cancer cells via the regulation of E-cadherin and CD44 expression. J Cell Physiol. 2019;234:19895\u2013910. https:\/\/doi.org\/10.1002\/jcp.28588.","journal-title":"J Cell Physiol"},{"key":"10184_CR33","first-page":"602","volume":"13","author":"G Hou","year":"2023","unstructured":"Hou G, et al. EIF4A3 induced circABCA5 promotes the gastric cancer progression by SPI1 mediated IL6\/JAK2\/STAT3 signaling. Am J Cancer Res. 2023;13:602\u201322.","journal-title":"Am J Cancer Res"},{"key":"10184_CR34","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-023-01759-1","volume":"22","author":"Z Hu","year":"2023","unstructured":"Hu Z, et al. Exosome-derived circCCAR1 promotes CD8\u2009+\u2009T-cell dysfunction and anti-PD1 resistance in hepatocellular carcinoma. Mol Cancer. 2023;22:55. https:\/\/doi.org\/10.1186\/s12943-023-01759-1.","journal-title":"Mol Cancer"},{"key":"10184_CR35","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-024-01940-0","volume":"23","author":"B Huang","year":"2024","unstructured":"Huang B, et al. A novel peptide PDHK1-241aa encoded by circPDHK1 promotes ccRCC progression via interacting with PPP1CA to inhibit AKT dephosphorylation and activate the AKT-mTOR signaling pathway. Mol Cancer. 2024;23:34. https:\/\/doi.org\/10.1186\/s12943-024-01940-0.","journal-title":"Mol Cancer"},{"key":"10184_CR36","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-020-03237-8","volume":"11","author":"Q Huang","year":"2020","unstructured":"Huang Q, et al. A novel circular RNA, circXPO1, promotes lung adenocarcinoma progression by interacting with IGF2BP1. Cell Death Dis. 2020;11:1031. https:\/\/doi.org\/10.1038\/s41419-020-03237-8.","journal-title":"Cell Death Dis"},{"key":"10184_CR37","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-019-0969-3","volume":"18","author":"X Huang","year":"2019","unstructured":"Huang X, et al. Circular RNA AKT3 upregulates PIK3R1 to enhance cisplatin resistance in gastric cancer via miR-198 suppression. Mol Cancer. 2019a;18:71. https:\/\/doi.org\/10.1186\/s12943-019-0969-3.","journal-title":"Mol Cancer"},{"key":"10184_CR38","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1016\/j.ccell.2019.03.006","volume":"35","author":"Y Huang","year":"2019","unstructured":"Huang Y, et al. Small-Molecule Targeting of Oncogenic FTO Demethylase in Acute Myeloid Leukemia. Cancer Cell. 2019b;35:677-91.e10. https:\/\/doi.org\/10.1016\/j.ccell.2019.03.006.","journal-title":"Cancer Cell"},{"key":"10184_CR39","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2025.288221","author":"AK Jaiswal","year":"2025","unstructured":"Jaiswal AK, et al. A small molecule inhibitor of RNA-binding protein IGF2BP3 shows anti-leukemic activity. Haematologica. 2025. https:\/\/doi.org\/10.3324\/haematol.2025.288221.","journal-title":"Haematologica"},{"key":"10184_CR40","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2024-010041","author":"Z Ji","year":"2024","unstructured":"Ji Z, et al. Multiomics reveals tumor microenvironment remodeling in locally advanced gastric and gastroesophageal junction cancer following neoadjuvant immunotherapy and chemotherapy. J Immunother Cancer. 2024. https:\/\/doi.org\/10.1136\/jitc-2024-010041.","journal-title":"J Immunother Cancer"},{"key":"10184_CR41","doi-asserted-by":"publisher","first-page":"1597","DOI":"10.2147\/ijn.S502400","volume":"20","author":"S Jiang","year":"2025","unstructured":"Jiang S, et al. CircPRMT5, a Potential Salivary Biomarker, Facilitates the Progression of Head and Neck Squamous Cell Carcinoma via the IGF2BP3-SERPINE1 Pathway. Int J Nanomedicine. 2025;20:1597\u2013613. https:\/\/doi.org\/10.2147\/ijn.S502400.","journal-title":"Int J Nanomedicine"},{"key":"10184_CR42","doi-asserted-by":"publisher","first-page":"831","DOI":"10.1158\/0008-5472.Can-21-2988","volume":"82","author":"X Jiang","year":"2022","unstructured":"Jiang X, et al. EIF4A3-induced circARHGAP29 promotes aerobic glycolysis in docetaxel-resistant prostate cancer through IGF2BP2\/c-Myc\/LDHA signaling. Cancer Res. 2022;82:831\u201345. https:\/\/doi.org\/10.1158\/0008-5472.Can-21-2988.","journal-title":"Cancer Res"},{"key":"10184_CR43","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1038\/s41418-024-01406-2","volume":"32","author":"X Jin","year":"2025","unstructured":"Jin X, et al. METTL3 confers oxaliplatin resistance through the activation of G6PD-enhanced pentose phosphate pathway in hepatocellular carcinoma. Cell Death Differ. 2025;32:466\u201379. https:\/\/doi.org\/10.1038\/s41418-024-01406-2.","journal-title":"Cell Death Differ"},{"key":"10184_CR44","doi-asserted-by":"publisher","first-page":"6518","DOI":"10.1093\/nar\/gkw236","volume":"44","author":"RL Juliano","year":"2016","unstructured":"Juliano RL. The delivery of therapeutic oligonucleotides. Nucleic Acids Res. 2016;44:6518\u201348. https:\/\/doi.org\/10.1093\/nar\/gkw236.","journal-title":"Nucleic Acids Res"},{"key":"10184_CR45","doi-asserted-by":"publisher","unstructured":"Kalluri R, LeBleu VS. The biology, function, and biomedical applications of exosomes. Science (New York, NY). 2020;367. \nhttps:\/\/doi.org\/10.1126\/science.aau6977.","DOI":"10.1126\/science.aau6977"},{"key":"10184_CR46","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1016\/s1470-2045(08)70035-4","volume":"9","author":"W Koizumi","year":"2008","unstructured":"Koizumi W, et al. S-1 plus cisplatin versus S-1 alone for first-line treatment of advanced gastric cancer (SPIRITS trial): a phase III trial. Lancet Oncol. 2008;9:215\u201321. https:\/\/doi.org\/10.1016\/s1470-2045(08)70035-4.","journal-title":"Lancet Oncol"},{"key":"10184_CR47","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1038\/s41416-019-0650-z","volume":"122","author":"N Koundouros","year":"2020","unstructured":"Koundouros N, Poulogiannis G. Reprogramming of fatty acid metabolism in cancer. Br J Cancer. 2020;122:4\u201322. https:\/\/doi.org\/10.1038\/s41416-019-0650-z.","journal-title":"Br J Cancer"},{"key":"10184_CR48","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1038\/s41576-019-0158-7","volume":"20","author":"LS Kristensen","year":"2019","unstructured":"Kristensen LS, Andersen MS, Stagsted LVW, Ebbesen KK, Hansen TB, Kjems J. The biogenesis, biology and characterization of circular RNAs. Nat Rev Genet. 2019;20:675\u201391. https:\/\/doi.org\/10.1038\/s41576-019-0158-7.","journal-title":"Nat Rev Genet"},{"key":"10184_CR49","doi-asserted-by":"publisher","DOI":"10.1186\/s13046-024-03143-3","volume":"43","author":"J Lee","year":"2024","unstructured":"Lee J, et al. The DNA repair pathway as a therapeutic target to synergize with trastuzumab deruxtecan in HER2-targeted antibody-drug conjugate-resistant HER2-overexpressing breast cancer. J Exp Clin Cancer Res. 2024;43:236. https:\/\/doi.org\/10.1186\/s13046-024-03143-3.","journal-title":"J Exp Clin Cancer Res"},{"key":"10184_CR50","doi-asserted-by":"publisher","first-page":"30087","DOI":"10.3402\/jev.v4.30087","volume":"4","author":"T Lener","year":"2015","unstructured":"Lener T, et al. Applying extracellular vesicles based therapeutics in clinical trials - an ISEV position paper. J Extracell Vesicles. 2015;4:30087. https:\/\/doi.org\/10.3402\/jev.v4.30087.","journal-title":"J Extracell Vesicles"},{"key":"10184_CR51","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-20527-z","volume":"12","author":"B Li","year":"2021","unstructured":"Li B, et al. CircNDUFB2 inhibits non-small cell lung cancer progression via destabilizing IGF2BPs and activating anti-tumor immunity. Nat Commun. 2021;12:295. https:\/\/doi.org\/10.1038\/s41467-020-20527-z.","journal-title":"Nat Commun"},{"key":"10184_CR52","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1007\/s10616-022-00545-z","volume":"74","author":"D Li","year":"2022","unstructured":"Li D, et al. Silencing TRPM2 enhanced erastin- and RSL3-induced ferroptosis in gastric cancer cells through destabilizing HIF-1\u03b1 and Nrf2 proteins. Cytotechnology. 2022a;74:559\u201377. https:\/\/doi.org\/10.1007\/s10616-022-00545-z.","journal-title":"Cytotechnology"},{"key":"10184_CR53","doi-asserted-by":"publisher","DOI":"10.1007\/s00018-022-04129-0","volume":"79","author":"H Li","year":"2022","unstructured":"Li H, et al. METTL3 promotes oxaliplatin resistance of gastric cancer CD133+ stem cells by promoting PARP1 mRNA stability. Cell Mol Life Sci. 2022b;79:135. https:\/\/doi.org\/10.1007\/s00018-022-04129-0.","journal-title":"Cell Mol Life Sci"},{"key":"10184_CR54","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-023-01811-0","volume":"22","author":"K Li","year":"2023","unstructured":"Li K, et al. Enhancement of TKI sensitivity in lung adenocarcinoma through m6A-dependent translational repression of Wnt signaling by circ-FBXW7. Mol Cancer. 2023;22:103. https:\/\/doi.org\/10.1186\/s12943-023-01811-0.","journal-title":"Mol Cancer"},{"key":"10184_CR55","doi-asserted-by":"publisher","DOI":"10.1186\/s40001-025-02353-5","volume":"30","author":"P Li","year":"2025","unstructured":"Li P, Fang X, Huang D. Exploring m6A modifications in gastric cancer: from molecular mechanisms to clinical applications. Eur J Med Res. 2025;30:98. https:\/\/doi.org\/10.1186\/s40001-025-02353-5.","journal-title":"Eur J Med Res"},{"key":"10184_CR56","doi-asserted-by":"publisher","first-page":"380","DOI":"10.2174\/0113892029300694240612081006","volume":"25","author":"Q Li","year":"2024","unstructured":"Li Q, Chu Y, Yao Y, Song Q. FAT4 mutation is related to tumor mutation burden and favorable prognosis in gastric cancer. Curr Genomics. 2024a;25:380\u20139. https:\/\/doi.org\/10.2174\/0113892029300694240612081006.","journal-title":"Curr Genomics"},{"key":"10184_CR57","doi-asserted-by":"publisher","first-page":"4314","DOI":"10.1016\/j.molcel.2024.10.001","volume":"84","author":"Q Li","year":"2024","unstructured":"Li Q, et al. ZC3H14 facilitates backsplicing by binding to exon-intron boundary and 3\u2019 UTR. Mol Cell. 2024b;84:4314-33.e9. https:\/\/doi.org\/10.1016\/j.molcel.2024.10.001.","journal-title":"Mol Cell"},{"key":"10184_CR58","doi-asserted-by":"publisher","DOI":"10.1038\/s41420-024-02166-1","volume":"10","author":"X Li","year":"2024","unstructured":"Li X, Yang G, Ma L, Tang B, Tao T. N(6)-methyladenosine (m(6)A) writer METTL5 represses the ferroptosis and antitumor immunity of gastric cancer. Cell Death Discov. 2024c;10:402. https:\/\/doi.org\/10.1038\/s41420-024-02166-1.","journal-title":"Cell Death Discov"},{"key":"10184_CR59","doi-asserted-by":"publisher","first-page":"704","DOI":"10.1186\/s12967-024-05498-9","volume":"22","author":"Y Li","year":"2024","unstructured":"Li Y, et al. CircRHBDD1 promotes immune escape via IGF2BP2\/PD-L1 signaling and acts as a nanotherapeutic target in gastric cancer. J Transl Med. 2024d;22:704. https:\/\/doi.org\/10.1186\/s12967-024-05498-9.","journal-title":"J Transl Med"},{"key":"10184_CR60","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-024-02019-6","volume":"23","author":"Y Li","year":"2024","unstructured":"Li Y, et al. CircTRIM1 encodes TRIM1-269aa to promote chemoresistance and metastasis of TNBC via enhancing CaM-dependent MARCKS translocation and PI3K\/AKT\/mTOR activation. Mol Cancer. 2024e;23:102. https:\/\/doi.org\/10.1186\/s12943-024-02019-6.","journal-title":"Mol Cancer"},{"key":"10184_CR61","doi-asserted-by":"publisher","first-page":"981","DOI":"10.1038\/cr.2015.82","volume":"25","author":"Y Li","year":"2015","unstructured":"Li Y, et al. Circular RNA is enriched and stable in exosomes: a promising biomarker for cancer diagnosis. Cell Res. 2015;25:981\u20134. https:\/\/doi.org\/10.1038\/cr.2015.82.","journal-title":"Cell Res"},{"key":"10184_CR62","doi-asserted-by":"publisher","DOI":"10.1007\/s10616-025-00718-6","volume":"77","author":"X Liang","year":"2025","unstructured":"Liang X, Tan X, Pei L, Dong C. CircDHX33 suppresses glycolysis, malignant proliferation, and metastasis in prostate cancer by interacting with RNA-binding protein IGF2BP2 to destabilize its protein. Cytotechnology. 2025;77:56. https:\/\/doi.org\/10.1007\/s10616-025-00718-6.","journal-title":"Cytotechnology"},{"key":"10184_CR63","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1038\/nmeth.3453","volume":"12","author":"B Linder","year":"2015","unstructured":"Linder B, Grozhik AV, Olarerin-George AO, Meydan C, Mason CE, Jaffrey SR. Single-nucleotide-resolution mapping of m6A and m6Am throughout the transcriptome. Nat Methods. 2015;12:767\u201372. https:\/\/doi.org\/10.1038\/nmeth.3453.","journal-title":"Nat Methods"},{"key":"10184_CR64","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-019-1045-8","volume":"18","author":"H Liu","year":"2019","unstructured":"Liu H, et al. Correction to: Circular RNA YAP1 inhibits the proliferation and invasion of gastric cancer cells by regulating the miR-367-5p\/p27 Kip1 axis. Mol Cancer. 2019;18:117. https:\/\/doi.org\/10.1186\/s12943-019-1045-8.","journal-title":"Mol Cancer"},{"key":"10184_CR65","doi-asserted-by":"publisher","first-page":"1316","DOI":"10.1002\/bab.2631","volume":"71","author":"J Liu","year":"2024","unstructured":"Liu J, Fang X. Regulation of hsa_circ_0112136 by m6A demethylase FTO can enhance the malignancy of gastric cancer via the regulation of the PI3K\/AKT\/mTOR pathway. Biotechnol Appl Biochem. 2024;71:1316\u201328. https:\/\/doi.org\/10.1002\/bab.2631.","journal-title":"Biotechnol Appl Biochem"},{"key":"10184_CR66","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1038\/s41419-020-02998-6","volume":"11","author":"R Liu","year":"2020","unstructured":"Liu R, et al. PI3K\/AKT pathway as a key link modulates the multidrug resistance of cancers. Cell Death Dis. 2020;11:797. https:\/\/doi.org\/10.1038\/s41419-020-02998-6.","journal-title":"Cell Death Dis"},{"key":"10184_CR67","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-025-02254-5","volume":"24","author":"W Liu","year":"2025","unstructured":"Liu W, et al. Role of circular RNAs in cancer therapy resistance. Mol Cancer. 2025;24:55. https:\/\/doi.org\/10.1186\/s12943-025-02254-5.","journal-title":"Mol Cancer"},{"key":"10184_CR68","doi-asserted-by":"publisher","DOI":"10.1016\/j.drup.2022.100886","volume":"65","author":"Z Liu","year":"2022","unstructured":"Liu Z, et al. N6-methyladenosine-modified circular RNA QSOX1 promotes colorectal cancer resistance to anti-CTLA-4 therapy through induction of intratumoral regulatory T cells. Drug Resist Updat. 2022;65:100886. https:\/\/doi.org\/10.1016\/j.drup.2022.100886.","journal-title":"Drug Resist Updat"},{"key":"10184_CR69","doi-asserted-by":"publisher","DOI":"10.1111\/jcmm.18465","volume":"28","author":"Z Liu","year":"2024","unstructured":"Liu Z, et al. EIF4A3-induced CircDHTKD1 regulates glycolysis in non-small cell lung cancer via stabilizing PFKL. J Cell Mol Med. 2024;28:e18465. https:\/\/doi.org\/10.1111\/jcmm.18465.","journal-title":"J Cell Mol Med"},{"key":"10184_CR70","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202401399","volume":"11","author":"Y Lu","year":"2024","unstructured":"Lu Y, et al. Lactylation-Driven IGF2BP3-Mediated Serine Metabolism Reprogramming and RNA m6A-Modification Promotes Lenvatinib Resistance in HCC. Advanced Science (Weinheim, Baden-Wurttemberg, Germany). 2024;11:e2401399. https:\/\/doi.org\/10.1002\/advs.202401399.","journal-title":"Advanced Science (Weinheim, Baden-Wurttemberg, Germany)"},{"key":"10184_CR71","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbadis.2025.167793","volume":"1871","author":"Z Lu","year":"2025","unstructured":"Lu Z, Lyu Z, Dong P, Liu Y, Huang L. N6-methyladenosine RNA modification in stomach carcinoma: novel insights into mechanisms and implications for diagnosis and treatment. Biochimica Et Biophysica Acta (BBA) - Molecular Basis of Disease. 2025;1871:167793. https:\/\/doi.org\/10.1016\/j.bbadis.2025.167793.","journal-title":"Biochimica Et Biophysica Acta (BBA) - Molecular Basis of Disease"},{"key":"10184_CR72","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1089\/dna.2024.0197","volume":"44","author":"L Luo","year":"2025","unstructured":"Luo L, Sun Y, Cao Z. METTL3-induced m6A modification enhances Hsa_Circ_0136959 expression to impair the tumor characteristics of papillary thyroid carcinoma via accelerating ferroptosis. DNA Cell Biol. 2025;44:99\u2013108. https:\/\/doi.org\/10.1089\/dna.2024.0197.","journal-title":"DNA Cell Biol"},{"key":"10184_CR73","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1002\/hep.28885","volume":"65","author":"JZ Ma","year":"2017","unstructured":"Ma JZ, et al. METTL14 suppresses the metastatic potential of hepatocellular carcinoma by modulating N(6) -methyladenosine-dependent primary MicroRNA processing. Hepatology. 2017;65:529\u201343. https:\/\/doi.org\/10.1002\/hep.28885.","journal-title":"Hepatology"},{"key":"10184_CR74","doi-asserted-by":"publisher","DOI":"10.1186\/s13046-022-02466-3","volume":"41","author":"Q Ma","year":"2022","unstructured":"Ma Q, et al. CircARID1A binds to IGF2BP3 in gastric cancer and promotes cancer proliferation by forming a circARID1A-IGF2BP3-SLC7A5 RNA-protein ternary complex. Journal of Experimental & Clinical Cancer Research\u202f: CR. 2022;41:251. https:\/\/doi.org\/10.1186\/s13046-022-02466-3.","journal-title":"Journal of Experimental & Clinical Cancer Research : CR"},{"key":"10184_CR75","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1038\/nature11928","volume":"495","author":"S Memczak","year":"2013","unstructured":"Memczak S, et al. Circular RNAs are a large class of animal RNAs with regulatory potency. Nature. 2013;495:333\u20138. https:\/\/doi.org\/10.1038\/nature11928.","journal-title":"Nature"},{"key":"10184_CR76","doi-asserted-by":"publisher","first-page":"1275","DOI":"10.1038\/s41592-019-0570-0","volume":"16","author":"KD Meyer","year":"2019","unstructured":"Meyer KD. DART-seq: an antibody-free method for global m(6)A detection. Nat Methods. 2019;16:1275\u201380. https:\/\/doi.org\/10.1038\/s41592-019-0570-0.","journal-title":"Nat Methods"},{"key":"10184_CR77","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1186\/s12943-023-01883-y","volume":"22","author":"Z Miao","year":"2023","unstructured":"Miao Z, et al. Hsa_circ_0136666 stimulates gastric cancer progression and tumor immune escape by regulating the miR-375\/PRKDC Axis and PD-L1 phosphorylation. Mol Cancer. 2023;22:205. https:\/\/doi.org\/10.1186\/s12943-023-01883-y.","journal-title":"Mol Cancer"},{"key":"10184_CR78","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1038\/nrm3745","volume":"15","author":"K Minton","year":"2014","unstructured":"Minton K. RNA decay: stabilizing stemness through m(6)A. Nat Rev Mol Cell Biol. 2014;15:76\u20137. https:\/\/doi.org\/10.1038\/nrm3745.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"10184_CR79","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1038\/s41573-020-0090-8","volume":"20","author":"MJ Mitchell","year":"2021","unstructured":"Mitchell MJ, Billingsley MM, Haley RM, Wechsler ME, Peppas NA, Langer R. Engineering precision nanoparticles for drug delivery. Nat Rev Drug Discov. 2021;20:101\u201324. https:\/\/doi.org\/10.1038\/s41573-020-0090-8.","journal-title":"Nat Rev Drug Discov"},{"key":"10184_CR80","doi-asserted-by":"publisher","DOI":"10.1186\/s13008-024-00123-z","volume":"19","author":"Y Mou","year":"2024","unstructured":"Mou Y, Lv K. Extracellular vesicle-delivered hsa_circ_0090081 regulated by EIF4A3 enhances gastric cancer tumorigenesis. Cell Div. 2024;19:19. https:\/\/doi.org\/10.1186\/s13008-024-00123-z.","journal-title":"Cell Div"},{"key":"10184_CR81","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1038\/s41576-024-00806-x","volume":"26","author":"E O'Leary","year":"2025","unstructured":"O\u2019Leary E, Jiang Y, Kristensen LS, Hansen TB, Kjems J. The therapeutic potential of circular RNAs. Nat Rev Genet. 2025;26:230\u201344. https:\/\/doi.org\/10.1038\/s41576-024-00806-x.","journal-title":"Nat Rev Genet"},{"key":"10184_CR82","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1038\/nnano.2007.387","volume":"2","author":"D Peer","year":"2007","unstructured":"Peer D, Karp JM, Hong S, Farokhzad OC, Margalit R, Langer R. Nanocarriers as an emerging platform for cancer therapy. Nat Nanotechnol. 2007;2:751\u201360. https:\/\/doi.org\/10.1038\/nnano.2007.387.","journal-title":"Nat Nanotechnol"},{"key":"10184_CR83","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-020-01270-x","volume":"19","author":"L Peng","year":"2020","unstructured":"Peng L, et al. CircCUL2 regulates gastric cancer malignant transformation and cisplatin resistance by modulating autophagy activation via miR-142-3p\/ROCK2. Mol Cancer. 2020;19:156. https:\/\/doi.org\/10.1186\/s12943-020-01270-x.","journal-title":"Mol Cancer"},{"key":"10184_CR84","doi-asserted-by":"publisher","first-page":"390","DOI":"10.2174\/0113892029300608240531111743","volume":"25","author":"Z Peng","year":"2024","unstructured":"Peng Z, Fang C, Tong Z, Rao Q, Ren Z, Hu K. Crosstalk between cancer-associated fibroblasts and myeloid cells shapes the heterogeneous microenvironment of gastric cancer. Curr Genomics. 2024;25:390\u2013411. https:\/\/doi.org\/10.2174\/0113892029300608240531111743.","journal-title":"Curr Genomics"},{"key":"10184_CR85","doi-asserted-by":"publisher","first-page":"1554","DOI":"10.1007\/s12094-022-03070-9","volume":"25","author":"I Ploumaki","year":"2023","unstructured":"Ploumaki I, et al. Bcl-2 pathway inhibition in solid tumors: a review of clinical trials. Clin Transl Oncol. 2023;25:1554\u201378. https:\/\/doi.org\/10.1007\/s12094-022-03070-9.","journal-title":"Clin Transl Oncol"},{"key":"10184_CR86","doi-asserted-by":"publisher","DOI":"10.1186\/s13046-024-03032-9","volume":"43","author":"Y Qiao","year":"2024","unstructured":"Qiao Y, et al. Targeting FTO induces colorectal cancer ferroptotic cell death by decreasing SLC7A11\/GPX4 expression. Journal of experimental & clinical cancer research\u202f: CR. 2024;43:108. https:\/\/doi.org\/10.1186\/s13046-024-03032-9.","journal-title":"Journal of experimental & clinical cancer research : CR"},{"key":"10184_CR87","doi-asserted-by":"publisher","first-page":"1181","DOI":"10.1016\/s1470-2045(23)00515-6","volume":"24","author":"SY Rha","year":"2023","unstructured":"Rha SY, et al. Pembrolizumab plus chemotherapy versus placebo plus chemotherapy for HER2-negative advanced gastric cancer (KEYNOTE-859): a multicentre, randomised, double-blind, phase 3 trial. Lancet Oncol. 2023;24:1181\u201395. https:\/\/doi.org\/10.1016\/s1470-2045(23)00515-6.","journal-title":"Lancet Oncol"},{"key":"10184_CR88","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1186\/s12943-019-0958-6","volume":"18","author":"D Rong","year":"2019","unstructured":"Rong D, et al. CircPSMC3 suppresses the proliferation and metastasis of gastric cancer by acting as a competitive endogenous RNA through sponging miR-296-5p. Mol Cancer. 2019;18:25. https:\/\/doi.org\/10.1186\/s12943-019-0958-6.","journal-title":"Mol Cancer"},{"key":"10184_CR89","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1016\/j.cell.2015.03.030","volume":"161","author":"P Sharma","year":"2015","unstructured":"Sharma P, Allison JP. Immune checkpoint targeting in cancer therapy: toward combination strategies with curative potential. Cell. 2015;161:205\u201314. https:\/\/doi.org\/10.1016\/j.cell.2015.03.030.","journal-title":"Cell"},{"key":"10184_CR90","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1016\/s1470-2045(23)00541-7","volume":"25","author":"K Shitara","year":"2024","unstructured":"Shitara K, et al. Neoadjuvant and adjuvant pembrolizumab plus chemotherapy in locally advanced gastric or gastro-oesophageal cancer (KEYNOTE-585): an interim analysis of the multicentre, double-blind, randomised phase 3 study. Lancet Oncol. 2024;25:212\u201324. https:\/\/doi.org\/10.1016\/s1470-2045(23)00541-7.","journal-title":"Lancet Oncol"},{"key":"10184_CR91","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-025-02261-6","volume":"24","author":"X Song","year":"2025","unstructured":"Song X, et al. CircAKT3 promotes prostate cancer proliferation and metastasis by enhancing the binding of RPS27A and RPL11. Mol Cancer. 2025;24:53. https:\/\/doi.org\/10.1186\/s12943-025-02261-6.","journal-title":"Mol Cancer"},{"key":"10184_CR92","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1016\/j.cell.2017.11.031","volume":"172","author":"R Su","year":"2018","unstructured":"Su R, et al. R-2HG exhibits anti-tumor activity by targeting FTO\/m(6)A\/MYC\/CEBPA signaling. Cell. 2018;172:90-105.e23. https:\/\/doi.org\/10.1016\/j.cell.2017.11.031.","journal-title":"Cell"},{"key":"10184_CR93","doi-asserted-by":"publisher","first-page":"10111","DOI":"10.1038\/s41598-018-27837-9","volume":"8","author":"HD Sun","year":"2018","unstructured":"Sun HD, et al. Down-regulation of circPVRL3 promotes the proliferation and migration of gastric cancer cells. Sci Rep. 2018;8:10111. https:\/\/doi.org\/10.1038\/s41598-018-27837-9.","journal-title":"Sci Rep"},{"key":"10184_CR94","doi-asserted-by":"publisher","DOI":"10.1186\/s13046-020-01758-w","volume":"39","author":"G Sun","year":"2020","unstructured":"Sun G, et al. Circular RNA MCTP2 inhibits cisplatin resistance in gastric cancer by miR-99a-5p-mediated induction of MTMR3 expression. Journal of experimental & clinical cancer research\u202f: CR. 2020;39:246. https:\/\/doi.org\/10.1186\/s13046-020-01758-w.","journal-title":"Journal of experimental & clinical cancer research : CR"},{"key":"10184_CR95","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijbiomac.2024.138534","volume":"286","author":"H Sun","year":"2025","unstructured":"Sun H, et al. m6A-modified circCREBBP enhances radiosensitivity of esophageal squamous cell carcinoma by reducing the stability of MYC through interaction with IGF2BP3. Int J Biol Macromol. 2025;286:138534. https:\/\/doi.org\/10.1016\/j.ijbiomac.2024.138534.","journal-title":"Int J Biol Macromol"},{"key":"10184_CR96","doi-asserted-by":"publisher","first-page":"3388","DOI":"10.1038\/s41388-024-03155-5","volume":"43","author":"Z Sun","year":"2024","unstructured":"Sun Z, et al. Targeting CircAURKA prevents colorectal cancer progression via enhancing CTNNB1 protein degradation. Oncogene. 2024;43:3388\u2013401. https:\/\/doi.org\/10.1038\/s41388-024-03155-5.","journal-title":"Oncogene"},{"key":"10184_CR97","doi-asserted-by":"publisher","DOI":"10.1186\/s13046-024-03029-4","volume":"43","author":"D Suo","year":"2024","unstructured":"Suo D, et al. HSPA4 upregulation induces immune evasion via ALKBH5\/CD58 axis in gastric cancer. J Exp Clin Cancer Res. 2024;43:106. https:\/\/doi.org\/10.1186\/s13046-024-03029-4.","journal-title":"J Exp Clin Cancer Res"},{"key":"10184_CR98","doi-asserted-by":"publisher","first-page":"194","DOI":"10.2174\/0109298665350654250111144722","volume":"32","author":"Q Suyila","year":"2025","unstructured":"Suyila Q, Li X, Su X. Anti-cancer bioactive peptide induces apoptosis in gastric cancer cells through TP53 signaling cascade. Protein Pept Lett. 2025;32:194\u2013205. https:\/\/doi.org\/10.2174\/0109298665350654250111144722.","journal-title":"Protein Pept Lett"},{"key":"10184_CR99","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1038\/nrg.2016.114","volume":"17","author":"L Szabo","year":"2016","unstructured":"Szabo L, Salzman J. Detecting circular RNAs: bioinformatic and experimental challenges. Nat Rev Genet. 2016;17:679\u201392. https:\/\/doi.org\/10.1038\/nrg.2016.114.","journal-title":"Nat Rev Genet"},{"key":"10184_CR100","doi-asserted-by":"publisher","first-page":"468","DOI":"10.1111\/j.1600-0854.2010.01034.x","volume":"11","author":"N Taguchi-Atarashi","year":"2010","unstructured":"Taguchi-Atarashi N, et al. Modulation of local PtdIns3P levels by the PI phosphatase MTMR3 regulates constitutive autophagy. Traffic (Copenhagen, Denmark). 2010;11:468\u201378. https:\/\/doi.org\/10.1111\/j.1600-0854.2010.01034.x.","journal-title":"Traffic (Copenhagen, Denmark)"},{"key":"10184_CR101","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2024.217254","volume":"604","author":"YT Tan","year":"2024","unstructured":"Tan YT, et al. WTAP weakens oxaliplatin chemosensitivity of colorectal cancer by preventing PANoptosis. Cancer Lett. 2024;604:217254. https:\/\/doi.org\/10.1016\/j.canlet.2024.217254.","journal-title":"Cancer Lett"},{"key":"10184_CR102","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1038\/s41416-023-02275-1","volume":"129","author":"Q Tang","year":"2023","unstructured":"Tang Q, et al. RNA modifications in cancer. Br J Cancer. 2023;129:204\u201321. https:\/\/doi.org\/10.1038\/s41416-023-02275-1.","journal-title":"Br J Cancer"},{"key":"10184_CR103","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-018-0888-8","volume":"17","author":"W Tang","year":"2018","unstructured":"Tang W, Fu K, Sun H, Rong D, Wang H, Cao H. CircRNA microarray profiling identifies a novel circulating biomarker for detection of gastric cancer. Mol Cancer. 2018;17:137. https:\/\/doi.org\/10.1186\/s12943-018-0888-8.","journal-title":"Mol Cancer"},{"key":"10184_CR104","doi-asserted-by":"publisher","first-page":"1535750","DOI":"10.1080\/20013078.2018.1535750","volume":"7","author":"C Th\u00e9ry","year":"2018","unstructured":"Th\u00e9ry C, et al. Minimal information for studies of extracellular vesicles 2018 (MISEV2018): a position statement of the International Society for Extracellular Vesicles and update of the MISEV2014 guidelines. J Extracell Vesicles. 2018;7:1535750. https:\/\/doi.org\/10.1080\/20013078.2018.1535750.","journal-title":"J Extracell Vesicles"},{"key":"10184_CR105","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1016\/j.ccell.2018.03.012","volume":"33","author":"DS Thommen","year":"2018","unstructured":"Thommen DS, Schumacher TN. T Cell Dysfunction in Cancer. Cancer Cell. 2018;33:547\u201362. https:\/\/doi.org\/10.1016\/j.ccell.2018.03.012.","journal-title":"Cancer Cell"},{"key":"10184_CR106","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1080\/15476286.2021.2010983","volume":"19","author":"N Wallis","year":"2022","unstructured":"Wallis N, et al. Small molecule inhibitor of Igf2bp1 represses Kras and a pro-oncogenic phenotype in cancer cells. RNA Biol. 2022;19:26\u201343. https:\/\/doi.org\/10.1080\/15476286.2021.2010983.","journal-title":"RNA Biol"},{"key":"10184_CR107","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1002\/cac2.12534","volume":"44","author":"J Wang","year":"2024","unstructured":"Wang J, et al. N6-methyladenosine reader hnRNPA2B1 recognizes and stabilizes NEAT1 to confer chemoresistance in gastric cancer. Cancer Commun (Lond). 2024a;44:469\u201390. https:\/\/doi.org\/10.1002\/cac2.12534.","journal-title":"Cancer Commun (Lond)"},{"key":"10184_CR108","doi-asserted-by":"publisher","first-page":"147","DOI":"10.2174\/0115665232247694230921060213","volume":"24","author":"K Wang","year":"2024","unstructured":"Wang K, et al. A Retrospective Analysis of the Lauren Classification in the Choice of XELOX or SOX as an Adjuvant Chemotherapy for Gastric Cancer. Curr Gene Ther. 2024b;24:147\u201358. https:\/\/doi.org\/10.2174\/0115665232247694230921060213.","journal-title":"Curr Gene Ther"},{"key":"10184_CR109","doi-asserted-by":"publisher","unstructured":"Wang L, et al. CircRNA-ST6GALNAC6 increases the sensitivity of bladder cancer cells to erastin-induced ferroptosis by regulating the HSPB1\/P38 axis. Laboratory investigation; a journal of technical methods and pathology. 2022;102:1323\u201334. \nhttps:\/\/doi.org\/10.1038\/s41374-022-00826-3.","DOI":"10.1038\/s41374-022-00826-3"},{"key":"10184_CR110","doi-asserted-by":"publisher","first-page":"1193","DOI":"10.1136\/gutjnl-2019-319639","volume":"69","author":"Q Wang","year":"2020","unstructured":"Wang Q, et al. METTL3-mediated m(6)A modification of HDGF mRNA promotes gastric cancer progression and has prognostic significance. Gut. 2020a;69:1193\u2013205. https:\/\/doi.org\/10.1136\/gutjnl-2019-319639.","journal-title":"Gut"},{"key":"10184_CR111","doi-asserted-by":"publisher","DOI":"10.1186\/s12967-025-06226-7","volume":"23","author":"S Wang","year":"2025","unstructured":"Wang S, et al. Hsa_circ_0002301 inhibits ferroptosis in gastric cancer by encoding the de novo protein HECTD1-463aa. J Transl Med. 2025a;23:250. https:\/\/doi.org\/10.1186\/s12967-025-06226-7.","journal-title":"J Transl Med"},{"key":"10184_CR112","doi-asserted-by":"publisher","DOI":"10.1016\/j.redox.2019.101319","volume":"28","author":"S Wang","year":"2020","unstructured":"Wang S, et al. PRDX2 protects against oxidative stress induced by H. pylori and promotes resistance to cisplatin in gastric cancer. Redox Biol. 2020b;28:101319. https:\/\/doi.org\/10.1016\/j.redox.2019.101319.","journal-title":"Redox Biol"},{"key":"10184_CR113","doi-asserted-by":"publisher","DOI":"10.1038\/s42003-024-06274-7","volume":"7","author":"S Wang","year":"2024","unstructured":"Wang S, Zhu X, Hao Y, Su TT, Shi W. ALKBH5-mediated m6A modification of circFOXP1 promotes gastric cancer progression by regulating SOX4 expression and sponging miR-338-3p. Commun Biol. 2024c;7:565. https:\/\/doi.org\/10.1038\/s42003-024-06274-7.","journal-title":"Commun Biol"},{"key":"10184_CR114","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-020-01204-7","volume":"19","author":"T Wang","year":"2020","unstructured":"Wang T, Kong S, Tao M, Ju S. The potential role of RNA N6-methyladenosine in Cancer progression. Mol Cancer. 2020c;19:88. https:\/\/doi.org\/10.1186\/s12943-020-01204-7.","journal-title":"Mol Cancer"},{"key":"10184_CR115","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2012881118","author":"X Wang","year":"2021","unstructured":"Wang X, et al. CircURI1 interacts with hnRNPM to inhibit metastasis by modulating alternative splicing in gastric cancer. Proc Natl Acad Sci U S A. 2021. https:\/\/doi.org\/10.1073\/pnas.2012881118.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10184_CR116","doi-asserted-by":"publisher","DOI":"10.1016\/j.tig.2025.11.001","author":"X Wang","year":"2025","unstructured":"Wang X, Shan G. Features and biomedical relevance of circular RNA biogenesis. Trends Genet. 2025. https:\/\/doi.org\/10.1016\/j.tig.2025.11.001.","journal-title":"Trends Genet"},{"key":"10184_CR117","doi-asserted-by":"publisher","DOI":"10.3390\/cancers17020253","author":"Z Wang","year":"2025","unstructured":"Wang Z, Chen W, Wang Z, Dai X. EIF4A3-Mediated circ_0008126 inhibits the progression and metastasis of gastric cancer by modulating the APC\/\u03b2-catenin pathway. Cancers. 2025b. https:\/\/doi.org\/10.3390\/cancers17020253.","journal-title":"Cancers"},{"key":"10184_CR118","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1158\/1535-7163.Mct-20-0316","volume":"20","author":"B Weadick","year":"2021","unstructured":"Weadick B, et al. Emt-induced gemcitabine resistance in pancreatic cancer involves the functional loss of equilibrative nucleoside transporter 1. Mol Cancer Ther. 2021;20:410\u201322. https:\/\/doi.org\/10.1158\/1535-7163.Mct-20-0316.","journal-title":"Mol Cancer Ther"},{"key":"10184_CR119","doi-asserted-by":"publisher","first-page":"6142","DOI":"10.1158\/0008-5472.Can-21-1518","volume":"81","author":"W Wei","year":"2021","unstructured":"Wei W, et al. Circ0008399 interaction with WTAP promotes assembly and activity of the m(6)A methyltransferase complex and promotes cisplatin resistance in bladder cancer. Cancer Res. 2021;81:6142\u201356. https:\/\/doi.org\/10.1158\/0008-5472.Can-21-1518.","journal-title":"Cancer Res"},{"key":"10184_CR120","doi-asserted-by":"publisher","DOI":"10.1186\/s43556-025-00314-2","volume":"6","author":"Y Wei","year":"2025","unstructured":"Wei Y, et al. The m(6)A modification in cancer: roles, implications, and its potential in therapy. Mol Biomed. 2025;6:67. https:\/\/doi.org\/10.1186\/s43556-025-00314-2.","journal-title":"Mol Biomed"},{"key":"10184_CR121","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1016\/j.stem.2017.11.016","volume":"22","author":"H Weng","year":"2018","unstructured":"Weng H, et al. METTL14 inhibits hematopoietic stem\/progenitor differentiation and promotes leukemogenesis via mRNA m(6)A modification. Cell Stem Cell. 2018;22:191-205 e9. https:\/\/doi.org\/10.1016\/j.stem.2017.11.016.","journal-title":"Cell Stem Cell"},{"key":"10184_CR122","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1038\/nri3862","volume":"15","author":"EJ Wherry","year":"2015","unstructured":"Wherry EJ, Kurachi M. Molecular and cellular insights into T cell exhaustion. Nat Rev Immunol. 2015;15:486\u201399. https:\/\/doi.org\/10.1038\/nri3862.","journal-title":"Nat Rev Immunol"},{"key":"10184_CR123","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-021-03558-2","volume":"12","author":"P Wu","year":"2021","unstructured":"Wu P, et al. N6-methyladenosine modification of circCUX1 confers radioresistance of hypopharyngeal squamous cell carcinoma through caspase1 pathway. Cell Death Dis. 2021;12:298. https:\/\/doi.org\/10.1038\/s41419-021-03558-2.","journal-title":"Cell Death Dis"},{"key":"10184_CR124","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2024.114111","volume":"43","author":"S Wu","year":"2024","unstructured":"Wu S, et al. Targeting high circDNA2v levels in colorectal cancer induces cellular senescence and elicits an anti-tumor secretome. Cell Rep. 2024a;43:114111. https:\/\/doi.org\/10.1016\/j.celrep.2024.114111.","journal-title":"Cell Rep"},{"key":"10184_CR125","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijbiomac.2025.144236","volume":"314","author":"X Wu","year":"2025","unstructured":"Wu X, et al. A novel DNA binding protein encoded by circZNF131 inhibits the growth of gastric cancer by suppressing CTBP2 transcription. Int J Biol Macromol. 2025;314:144236. https:\/\/doi.org\/10.1016\/j.ijbiomac.2025.144236.","journal-title":"Int J Biol Macromol"},{"key":"10184_CR126","doi-asserted-by":"publisher","DOI":"10.1186\/s43556-024-00172-4","volume":"5","author":"X Wu","year":"2024","unstructured":"Wu X, et al. Fat mass and obesity-associated protein (FTO) mediated m(6)A modification of circFAM192A promoted gastric cancer proliferation by suppressing SLC7A5 decay. Mol Biomed. 2024b;5:11. https:\/\/doi.org\/10.1186\/s43556-024-00172-4.","journal-title":"Mol Biomed"},{"key":"10184_CR127","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1186\/s12943-020-01208-3","volume":"19","author":"M Xie","year":"2020","unstructured":"Xie M, et al. Exosomal circSHKBP1 promotes gastric cancer progression via regulating the miR-582-3p\/HUR\/VEGF axis and suppressing HSP90 degradation. Mol Cancer. 2020;19:112. https:\/\/doi.org\/10.1186\/s12943-020-01208-3.","journal-title":"Mol Cancer"},{"key":"10184_CR128","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1007\/s10120-023-01437-7","volume":"27","author":"R Xie","year":"2024","unstructured":"Xie R, Liu L, Lu X, He C, Yao H, Li G. N6-methyladenosine modification of OIP5-AS1 promotes glycolysis, tumorigenesis, and metastasis of gastric cancer by inhibiting Trim21-mediated hnRNPA1 ubiquitination and degradation. Gastric Cancer. 2024;27:49\u201371. https:\/\/doi.org\/10.1007\/s10120-023-01437-7.","journal-title":"Gastric Cancer"},{"key":"10184_CR129","doi-asserted-by":"publisher","DOI":"10.1016\/j.yexcr.2024.114315","volume":"443","author":"L Xin","year":"2024","unstructured":"Xin L, et al. Methionine restriction promotes cisplatin sensitivity of gastric cancer resistant cells by down-regulating circ-CDK13 level. Exp Cell Res. 2024;443:114315. https:\/\/doi.org\/10.1016\/j.yexcr.2024.114315.","journal-title":"Exp Cell Res"},{"key":"10184_CR130","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1038\/s41419-022-05132-w","volume":"13","author":"W Xu","year":"2022","unstructured":"Xu W, et al. m6A RNA methylation-mediated NDUFA4 promotes cell proliferation and metabolism in gastric cancer. Cell Death Dis. 2022;13:715. https:\/\/doi.org\/10.1038\/s41419-022-05132-w.","journal-title":"Cell Death Dis"},{"key":"10184_CR131","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1186\/s12943-025-02239-4","volume":"24","author":"X Xu","year":"2025","unstructured":"Xu X, et al. CircRNF13 enhances IGF2BP1 phase separation-mediated ITGB1 mRNA stabilization in an m6A-dependent manner to promote oral cancer cisplatin chemoresistance. Mol Cancer. 2025;24:36. https:\/\/doi.org\/10.1186\/s12943-025-02239-4.","journal-title":"Mol Cancer"},{"key":"10184_CR132","doi-asserted-by":"publisher","DOI":"10.1111\/cpr.13344","volume":"56","author":"F Yang","year":"2023","unstructured":"Yang F, et al. Circ-CTNNB1 drives aerobic glycolysis and osteosarcoma progression via m6A modification through interacting with RBM15. Cell Prolif. 2023a;56:e13344. https:\/\/doi.org\/10.1111\/cpr.13344.","journal-title":"Cell Prolif"},{"key":"10184_CR133","doi-asserted-by":"publisher","DOI":"10.1186\/s12967-023-04235-y","volume":"21","author":"F Yang","year":"2023","unstructured":"Yang F, et al. CircNFATC3 promotes the proliferation of gastric cancer through binding to IGF2BP3 and restricting its ubiquitination to enhance CCND1 mRNA stability. J Transl Med. 2023b;21:402. https:\/\/doi.org\/10.1186\/s12967-023-04235-y.","journal-title":"J Transl Med"},{"key":"10184_CR134","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1186\/s40364-023-00495-4","volume":"11","author":"X Yang","year":"2023","unstructured":"Yang X, et al. EIF4A3-induced Circ_0001187 facilitates AML suppression through promoting ubiquitin-proteasomal degradation of METTL3 and decreasing m6A modification level mediated by miR-499a-5p\/RNF113A pathway. Biomark Res. 2023c;11:59. https:\/\/doi.org\/10.1186\/s40364-023-00495-4.","journal-title":"Biomark Res"},{"key":"10184_CR135","doi-asserted-by":"publisher","first-page":"1057","DOI":"10.1038\/s41375-024-02189-8","volume":"38","author":"X Yang","year":"2024","unstructured":"Yang X, et al. CircFAM193B interaction with PRMT6 regulates AML leukemia stem cells chemoresistance through altering the oxidative metabolism and lipid peroxidation. Leukemia. 2024;38:1057\u201371. https:\/\/doi.org\/10.1038\/s41375-024-02189-8.","journal-title":"Leukemia"},{"key":"10184_CR136","doi-asserted-by":"publisher","first-page":"A93","DOI":"10.1136\/gutjnl-2025-IDDF.53","volume":"74","author":"Y Yang","year":"2025","unstructured":"Yang Y, et al. IDDF2025-ABS-0062\u2005ALKBH5-dependent upregulation of circARHGEF12 by oridonin impairs gastric cancer progression and cisplatin resistance via regulating miR-130b-5p\/LATS2 signaling. Gut. 2025;74:A93\u20134. https:\/\/doi.org\/10.1136\/gutjnl-2025-IDDF.53.","journal-title":"Gut"},{"key":"10184_CR137","doi-asserted-by":"publisher","DOI":"10.1016\/j.cellsig.2025.112295","volume":"139","author":"Y Yang","year":"2026","unstructured":"Yang Y, Ye H, Qin S, Lin M, Liu Y, Li X. M6A reader IGF2BP3 stabili1zes SLC7A11 to antagonize ferroptosis and promote gastric tumorigenesis. Cell Signal. 2026;139:112295. https:\/\/doi.org\/10.1016\/j.cellsig.2025.112295.","journal-title":"Cell Signal"},{"key":"10184_CR138","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1038\/s41586-021-03536-w","volume":"593","author":"E Yankova","year":"2021","unstructured":"Yankova E, et al. Small-molecule inhibition of METTL3 as a strategy against myeloid leukaemia. Nature. 2021;593:597\u2013601. https:\/\/doi.org\/10.1038\/s41586-021-03536-w.","journal-title":"Nature"},{"key":"10184_CR139","doi-asserted-by":"publisher","DOI":"10.3892\/ijmm.2025.5605","author":"Q Yi","year":"2025","unstructured":"Yi Q, et al. M6A modification of non\u2011coding RNA: mechanisms, functions and potential values in human diseases (Review). Int J Mol Med. 2025. https:\/\/doi.org\/10.3892\/ijmm.2025.5605.","journal-title":"Int J Mol Med"},{"key":"10184_CR140","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1053\/j.gastro.2023.10.013","volume":"166","author":"HW Yoo","year":"2024","unstructured":"Yoo HW, Hong SJ, Kim SH. Helicobacter pylori treatment and gastric cancer risk after endoscopic resection of dysplasia: a nationwide cohort study. Gastroenterology. 2024;166:313-22 e3. https:\/\/doi.org\/10.1053\/j.gastro.2023.10.013.","journal-title":"Gastroenterology"},{"key":"10184_CR141","doi-asserted-by":"publisher","DOI":"10.1002\/adma.202204910","volume":"35","author":"Q You","year":"2023","unstructured":"You Q, et al. m(6) A Reader YTHDF1-Targeting Engineered Small Extracellular Vesicles for Gastric Cancer Therapy via Epigenetic and Immune Regulation. Advanced Materials (Deerfield Beach, Fla). 2023;35:e2204910. https:\/\/doi.org\/10.1002\/adma.202204910.","journal-title":"Advanced Materials (Deerfield Beach, Fla)"},{"key":"10184_CR142","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2020.111075","volume":"133","author":"H Yu","year":"2021","unstructured":"Yu H, et al. N(6)-methyladenosine (m(6)A) methyltransferase WTAP accelerates the Warburg effect of gastric cancer through regulating HK2 stability. Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie. 2021a;133:111075. https:\/\/doi.org\/10.1016\/j.biopha.2020.111075.","journal-title":"Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie"},{"key":"10184_CR143","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1016\/j.omtn.2021.08.029","volume":"26","author":"T Yu","year":"2021","unstructured":"Yu T, et al. Circular RNA circ-TNPO3 suppresses metastasis of GC by acting as a protein decoy for IGF2BP3 to regulate the expression of MYC and SNAIL. Mol Ther Nucleic Acids. 2021b;26:649\u201364. https:\/\/doi.org\/10.1016\/j.omtn.2021.08.029.","journal-title":"Mol Ther Nucleic Acids"},{"key":"10184_CR144","doi-asserted-by":"publisher","DOI":"10.1016\/j.cellsig.2023.110699","volume":"108","author":"Y Yu","year":"2023","unstructured":"Yu Y, et al. m(6)A reader YTHDF3 is associated with clinical prognosis, related RNA signatures and immunosuppression in gastric cancer. Cell Signal. 2023;108:110699. https:\/\/doi.org\/10.1016\/j.cellsig.2023.110699.","journal-title":"Cell Signal"},{"key":"10184_CR145","doi-asserted-by":"publisher","first-page":"652","DOI":"10.1038\/s41586-021-03326-4","volume":"591","author":"R Zappasodi","year":"2021","unstructured":"Zappasodi R, et al. CTLA-4 blockade drives loss of T(reg) stability in glycolysis-low tumours. Nature. 2021;591:652\u20138. https:\/\/doi.org\/10.1038\/s41586-021-03326-4.","journal-title":"Nature"},{"key":"10184_CR146","doi-asserted-by":"publisher","first-page":"1744","DOI":"10.7150\/ijbs.86658","volume":"20","author":"Z Zeng","year":"2024","unstructured":"Zeng Z, et al. The m6A modification-mediated positive feedback between glycolytic lncRNA SLC2A1-DT and c-Myc promotes tumorigenesis of hepatocellular carcinoma. Int J Biol Sci. 2024;20:1744\u201362. https:\/\/doi.org\/10.7150\/ijbs.86658.","journal-title":"Int J Biol Sci"},{"key":"10184_CR147","doi-asserted-by":"publisher","first-page":"527","DOI":"10.2217\/fon.10.21","volume":"6","author":"D Zhang","year":"2010","unstructured":"Zhang D, Fan D. New insights into the mechanisms of gastric cancer multidrug resistance and future perspectives. Future oncology (London, England). 2010;6:527\u201337. https:\/\/doi.org\/10.2217\/fon.10.21.","journal-title":"Future oncology (London, England)"},{"key":"10184_CR148","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-017-0719-3","volume":"16","author":"J Zhang","year":"2017","unstructured":"Zhang J, et al. Circular RNA_LARP4 inhibits cell proliferation and invasion of gastric cancer by sponging miR-424-5p and regulating LATS1 expression. Mol Cancer. 2017;16:151. https:\/\/doi.org\/10.1186\/s12943-017-0719-3.","journal-title":"Mol Cancer"},{"key":"10184_CR149","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1186\/s12943-019-1015-1","volume":"18","author":"J Zhang","year":"2019","unstructured":"Zhang J, et al. CircDLST promotes the tumorigenesis and metastasis of gastric cancer by sponging miR-502-5p and activating the NRAS\/MEK1\/ERK1\/2 signaling. Mol Cancer. 2019a;18:80. https:\/\/doi.org\/10.1186\/s12943-019-1015-1.","journal-title":"Mol Cancer"},{"key":"10184_CR150","doi-asserted-by":"publisher","first-page":"3019","DOI":"10.7150\/ijbs.72534","volume":"18","author":"A Zhang","year":"2022","unstructured":"Zhang A, Miao K, Sun H, Deng CX. Tumor heterogeneity reshapes the tumor microenvironment to influence drug resistance. Int J Biol Sci. 2022a;18:3019\u201333. https:\/\/doi.org\/10.7150\/ijbs.72534.","journal-title":"Int J Biol Sci"},{"key":"10184_CR151","doi-asserted-by":"publisher","first-page":"1027","DOI":"10.2217\/epi-2019-0153","volume":"12","author":"C Zhang","year":"2020","unstructured":"Zhang C, et al. Circular RNA expression profile and m6A modification analysis in poorly differentiated adenocarcinoma of the stomach. Epigenomics. 2020a;12:1027\u201340. https:\/\/doi.org\/10.2217\/epi-2019-0153.","journal-title":"Epigenomics"},{"key":"10184_CR152","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-024-07317-x","volume":"16","author":"C Zhang","year":"2025","unstructured":"Zhang C, et al. METTL3 inhibition promotes radiosensitivity in hepatocellular carcinoma through regulation of SLC7A11 expression. Cell Death Dis. 2025a;16:9. https:\/\/doi.org\/10.1038\/s41419-024-07317-x.","journal-title":"Cell Death Dis"},{"key":"10184_CR153","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-020-01222-5","volume":"19","author":"PF Zhang","year":"2020","unstructured":"Zhang PF, et al. Cancer cell-derived exosomal circUHRF1 induces natural killer cell exhaustion and may cause resistance to anti-PD1 therapy in hepatocellular carcinoma. Mol Cancer. 2020b;19:110. https:\/\/doi.org\/10.1186\/s12943-020-01222-5.","journal-title":"Mol Cancer"},{"key":"10184_CR154","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1186\/s12943-018-0935-5","volume":"18","author":"X Zhang","year":"2019","unstructured":"Zhang X, et al. Circular RNA circNRIP1 acts as a microRNA-149-5p sponge to promote gastric cancer progression via the AKT1\/mTOR pathway. Mol Cancer. 2019b;18:20. https:\/\/doi.org\/10.1186\/s12943-018-0935-5.","journal-title":"Mol Cancer"},{"key":"10184_CR155","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-021-01390-y","volume":"20","author":"Y Zhang","year":"2021","unstructured":"Zhang Y, et al. CircDIDO1 inhibits gastric cancer progression by encoding a novel DIDO1-529aa protein and regulating PRDX2 protein stability. Mol Cancer. 2021;20:101. https:\/\/doi.org\/10.1186\/s12943-021-01390-y.","journal-title":"Mol Cancer"},{"key":"10184_CR156","doi-asserted-by":"publisher","DOI":"10.1002\/ctm2.70228","volume":"15","author":"Y Zhang","year":"2025","unstructured":"Zhang Y, et al. N(6)-methyladenosine modification mediated by METTL3 promotes DNA-PKcs expression to induce anlotinib resistance in osteosarcoma. Clin Transl Med. 2025b;15:e70228. https:\/\/doi.org\/10.1002\/ctm2.70228.","journal-title":"Clin Transl Med"},{"key":"10184_CR157","doi-asserted-by":"publisher","first-page":"3085","DOI":"10.1111\/cas.15469","volume":"113","author":"Y Zhang","year":"2022","unstructured":"Zhang Y, Gao LX, Wang W, Zhang T, Dong FY, Ding WP. M(6) a demethylase fat mass and obesity-associated protein regulates cisplatin resistance of gastric cancer by modulating autophagy activation through ULK1. Cancer Sci. 2022b;113:3085\u201396. https:\/\/doi.org\/10.1111\/cas.15469.","journal-title":"Cancer Sci"},{"key":"10184_CR158","doi-asserted-by":"publisher","first-page":"1090","DOI":"10.1038\/s41417-024-00786-4","volume":"31","author":"D Zheng","year":"2024","unstructured":"Zheng D, Chen W, Peng J, Huang X, Zhang S, Zhuang Y. Hsa_circ_0007590\/PTBP1 complex reprograms glucose metabolism by reducing the stability of m(6)A-modified PTEN mRNA in pancreatic ductal adenocarcinoma. Cancer Gene Ther. 2024;31:1090\u2013102. https:\/\/doi.org\/10.1038\/s41417-024-00786-4.","journal-title":"Cancer Gene Ther"},{"key":"10184_CR159","doi-asserted-by":"publisher","first-page":"1094","DOI":"10.1038\/ni.3830","volume":"18","author":"Q Zheng","year":"2017","unstructured":"Zheng Q, Hou J, Zhou Y, Li Z, Cao X. The RNA helicase DDX46 inhibits innate immunity by entrapping m(6)A-demethylated antiviral transcripts in the nucleus. Nat Immunol. 2017;18:1094\u2013103. https:\/\/doi.org\/10.1038\/ni.3830.","journal-title":"Nat Immunol"},{"key":"10184_CR160","doi-asserted-by":"publisher","DOI":"10.1093\/nsr\/nwae039","volume":"11","author":"J Zhou","year":"2024","unstructured":"Zhou J, et al. N6-methyladenosine facilitates mitochondrial fusion of colorectal cancer cells via induction of GSH synthesis and stabilization of OPA1 mRNA. Natl Sci Rev. 2024;11:nwae039. https:\/\/doi.org\/10.1093\/nsr\/nwae039.","journal-title":"Natl Sci Rev"},{"key":"10184_CR161","doi-asserted-by":"publisher","first-page":"2044","DOI":"10.1111\/cas.15351","volume":"113","author":"Y Zhou","year":"2022","unstructured":"Zhou Y, Zhang Q, Liao B, Qiu X, Hu S, Xu Q. circ_0006089 promotes gastric cancer growth, metastasis, glycolysis, and angiogenesis by regulating miR-361-3p\/TGFB1. Cancer Sci. 2022;113:2044\u201355. https:\/\/doi.org\/10.1111\/cas.15351.","journal-title":"Cancer Sci"},{"key":"10184_CR162","doi-asserted-by":"publisher","DOI":"10.3892\/ol.2021.12619","volume":"21","author":"Y Zhu","year":"2021","unstructured":"Zhu Y, Ren C, Yang L. Effect of eukaryotic translation initiation factor 4A3 in malignant tumors. Oncol Lett. 2021;21:358. https:\/\/doi.org\/10.3892\/ol.2021.12619.","journal-title":"Oncol Lett"}],"container-title":["Cell Biology and Toxicology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10565-026-10184-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10565-026-10184-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10565-026-10184-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,7]],"date-time":"2026-05-07T02:59:52Z","timestamp":1778122792000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10565-026-10184-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,28]]},"references-count":162,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["10184"],"URL":"https:\/\/doi.org\/10.1007\/s10565-026-10184-1","relation":{},"ISSN":["1573-6822"],"issn-type":[{"value":"1573-6822","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,28]]},"assertion":[{"value":"15 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Statement: During the preparation of this work, the author(s) used [Gemini\/ChatGTP] in order to [improve the readability and language of the manuscript]. After using this tool\/service, the author(s) reviewed and edited the content as needed and take(s) full responsibility for the content of the published article.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declaration of Generative AI and AI-assisted technologies in the writing process"}},{"value":"Clinical trial number: not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Clinical trial number"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"59"}}